You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

19 May 2022
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
26 August 2020
We have identified disinfectants as being critical in preventing the spread of COVID-19. This information provides advice on how to use disinfectants properly
26 August 2020
Frequently asked questions for consumers in relation to disinfectant products.
3 August 2020
Information on advertising of products related to COVID-19, GMP information for sponsors and manufacturers and access to coronavirus tests, medicines and vaccines, including medicine shortages
1 July 2020
Pharmacies can return children's paracetamol liquid formulations to front-of-counter, but the one unit limit on sales remains in place.
6 May 2020
Information on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19.
17 April 2020
The TGA has been involved in exploring ways to further increase supply of ventilators when and where they are needed
2 April 2020
Information about the steps we are taking to make sure there are enough ventilators to match demand during the COVID-19 pandemic
24 March 2020
Only certain types of specialists will now be able to prescribe hydroxychloroquine to new patients
24 March 2020

A delegate of the Secretary has made a decision to include an amendment to the Schedule 3 entry for salbutamol

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us